Distal airway dysfunction identifies pulmonary inflammation in asymptomatic smokers

ERJ Open Research

Volumn 2, Issue 4, 2016, Pages

  Berger, Kenneth I ^a,b   Pradhan, Deepak R ^a,b   Goldring, Roberta M ^a,b   Oppenheimer, Beno W ^a,b   Rom, William N ^b   Segal, Leopoldo N ^a,b  

^a BELLEVUE HOSPITAL CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EOTAXIN; FRACTALKINE; INTERLEUKIN 12P70; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; AGED; ARTICLE; ASYMPTOMATIC DISEASE; BRONCHOSCOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIAL LINING FLUID; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; LUNG DIFFUSION CAPACITY; LUNG LAVAGE; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NEUTROPHIL; PLETHYSMOGRAPHY; PNEUMONIA; RESPIRATORY FUNCTION; SMOKING; SPIROMETRY; X-RAY COMPUTED TOMOGRAPHY;

EID: 85017450389     PISSN: None     EISSN: 23120541     Source Type: Journal    
DOI: 10.1183/23120541.00066-2016     Document Type: Article

References (40)

1. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 2645-2653.
2. Mead J. The lung’s “quiet zone”. N Engl J Med 1970; 282: 1318-1319.
3. Miller MR, Crapo R, Hankinson J, et al. General considerations for lung function testing. Eur Respir J 2005; 26: 153-161.
4. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999; 159: 179-187.
5. Goldman HI, Becklake MR. Normal values at median altitudes and the prediction of normal results. Am Rev Tuberc 1959; 79: 457-467.
6. Van Ganse WF, Ferris BG Jr, Cotes JE. Cigarette smoking and pulmonary diffusing capacity (transfer factor). Am Rev Respir Dis 1972; 105: 30-41.
7. Oostveen E, MacLeod D, Lorino H, et al. The forced oscillation technique in clinical practice: methodology, recommendations and future developments. Eur Respir J 2003; 22: 1026-1041.
8. Komarow HD, Myles IA, Uzzaman A, et al. Impulse oscillometry in the evaluation of diseases of the airways in children. Ann Allergy Asthma Immunol 2011; 106: 191-199.
9. Oppenheimer BW, Goldring RM, Herberg ME, et al. Distal airway function in symptomatic subjects with normal spirometry following World Trade Center dust exposure. Chest 2007; 132: 1275-1282.
10. Friedman SM, Maslow CB, Reibman J, et al. Case-control study of lung function in World Trade Center Health Registry area residents and workers. Am J Respir Crit Care Med 2011; 184: 582-589.
11. Goldman MD, Saadeh C, Ross D. Clinical applications of forced oscillation to assess peripheral airway function. Respir Physiol Neurobiol 2005; 148: 179-194.
12. Kohlhäufl M, Brand P, Scheuch G, et al. Impulse oscillometry in healthy nonsmokers and asymptomatic smokers: effects of bronchial challenge with methacholine. J Aerosol Med 2001; 14: 1-12.
13. Newbury W, Crockett A, Newbury J. A pilot study to evaluate Australian predictive equations for the impulse oscillometry system. Respirology 2008; 13: 1070-1075.
14. Oostveen E, Boda K, van der Grinten CP, et al. Respiratory impedance in healthy subjects: baseline values and bronchodilator response. Eur Respir J 2013; 42: 1513-1523.
15. Rennard SI, Basset G, Lecossier D, et al. Estimation of volume of epithelial lining fluid recovered by lavage using urea as marker of dilution. J Appl Physiol 1986; 60: 532-538.
16. Reiner A, Yekutieli D, Benjamini Y. Identifying differentially expressed genes using false discovery rate controlling procedures. Bioinformatics 2003; 19: 368-375.
17. Hochberg Y, Benjamini Y. More powerful procedures for multiple significance testing. Stat Med 1990; 9: 811-818.
18. Orie NGM, Sluiter HJ, De Vries K, et al. The host factor in bronchitis. In: Orie NGM, Sluiter HJ, eds. Bronchitis. Assen, Royal Van Gorcum, 1961; pp. 43-59.
19. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD Executive Summary. Am J Respir Crit Care Med 2013; 187: 347-365.
20. Cosio MG, Cosio Piqueras MG. Pathology of emphysema in chronic obstructive pulmonary disease. Monaldi Arch Chest Dis 2000; 55: 124-129.
21. Cosio MG, Saetta M, Agustí A. Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 2009; 360: 2445-2454.
22. Cosio M, Ghezzo H, Hogg JC, et al. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med 1978; 298: 1277-1281.
23. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 1968; 278: 1355-1360.
24. McDonough JE, Yuan R, Suzuki M, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 2011; 365: 1567-1575.
25. Pedley TJ, Schroter RC, Sudlow MF. The prediction of pressure drop and variation of resistance within the human bronchial airways. Respir Physiol 1970; 9: 387-405.
26. Crim C, Celli B, Edwards LD, et al. Respiratory system impedance with impulse oscillometry in healthy and COPD subjects: ECLIPSE baseline results. Respir Med 2011; 105: 1069-1078.
27. Di Mango AM, Lopes AJ, Jansen JM, et al. Changes in respiratory mechanics with increasing degrees of airway obstruction in COPD: detection by forced oscillation technique. Respir Med 2006; 100: 399-410.
28. Frantz S, Nihlén U, Dencker M, et al. Impulse oscillometry may be of value in detecting early manifestations of COPD. Respir Med 2012; 106: 1116-1123.
29. Oppenheimer BW, Goldring RM, Berger KI. Distal airway function assessed by oscillometry at varying respiratory rate: comparison with dynamic compliance. COPD 2009; 6: 162-170.
30. O’Shaughnessy TC, Ansari TW, Barnes NC, et al. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. Am J Respir Crit Care Med 1997; 155: 852-857.
31. Fujimoto K, Yasuo M, Urushibata K, et al. Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease. Eur Respir J 2005; 25: 640-646.
32. Medina-Contreras O, Geem D, Laur O, et al. CX3CR1 regulates intestinal macrophage homeostasis, bacterial translocation, and colitogenic Th17 responses in mice. J Clin Invest 2011; 121: 4787-4795.
33. McComb JG, Ranganathan M, Liu XH, et al. CX3CL1 up-regulation is associated with recruitment of CX3CR1+ mononuclear phagocytes and T lymphocytes in the lungs during cigarette smoke-induced emphysema. Am J Pathol 2008; 173: 949-961.
34. Traves SL, Donnelly LE. Th17 cells in airway diseases. Curr Mol Med 2008; 8: 416-426.
35. Zhang L, Cheng Z, Liu W, et al. Expression of interleukin (IL)-10, IL-17A and IL-22 in serum and sputum of stable chronic obstructive pulmonary disease patients. COPD 2013; 10: 459-465.
36. Di Stefano A, Caramori G, Gnemmi I, et al. T helper type 17-related cytokine expression is increased in the bronchial mucosa of stable chronic obstructive pulmonary disease patients. Clin Exp Immunol 2009; 157: 316-324.
37. Saetta M, Di Stefano A, Turato G, et al. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 157: 822-826.
38. Miller M, Ramsdell J, Friedman PJ, et al. Computed tomographic scan-diagnosed chronic obstructive pulmonary disease-emphysema: eotaxin-1 is associated with bronchodilator response and extent of emphysema. J Allergy Clin Immunol 2007; 120: 1118-1125.
39. Joubert P, Lajoie-Kadoch S, Labonté I, et al. CCR3 expression and function in asthmatic airway smooth muscle cells. J Immunol 2005; 175: 2702-2708.
40. Hogg JC, Wright JL, Wiggs BR, et al. Lung structure and function in cigarette smokers. Thorax 1994; 49: 473-478.